Mitos Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 7

Mitos Therapeutics General Information

Description

Operator of a bio-venture company intended to develop mitochondrial-based anti-metabolic cancer drugs. The company specializes in restoring aging health, maintaining a homeostatic balance, and appropriately recognizing and responding to energy imbalances, helping patients to cure cancer and stay healthier by controlling energy intake and consumption.

Contact Information

Website
mitos.quv.kr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room Number 305, Industry-University-Research, Education-Research Building
  • 99 Daehak, Yuseong
  • Daejeon, 34134
  • South Korea
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • Room Number 305, Industry-University-Research, Education-Research Building
  • 99 Daehak, Yuseong
  • Daejeon, 34134
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mitos Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 15-Sep-2023 Completed Generating Revenue
4. Early Stage VC 10-Jun-2022 Completed Generating Revenue
3. Seed Round 01-Jun-2022 Completed Generating Revenue
2. Accelerator/Incubator 30-Sep-2021 Completed Startup
1. Seed Round 19-Jul-2021 Completed Startup
To view Mitos Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Mitos Therapeutics Patents

  • 11

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Mitos Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025230025-A1 Composition for reducing skin wrinkles or whitening skin comprising mitochondria-derived peptide with high skin permeability Pending 30-Apr-2024
WO-2025009664-A1 Composition comprising l-aspartic acid as active ingredient for promoting differentiation of myocytes or osteoblasts Inactive 03-Jul-2023
EP-4257139-A2 Composition for improving, preventing or treating muscular disorders comprising sulfonamide-based compounds Active 07-Apr-2022
EP-4257139-A3 Composition for improving, preventing or treating muscular disorders comprising sulfonamide-based compounds Active 07-Apr-2022
EP-4257139-B1 Composition for improving, preventing or treating muscular disorders comprising sulfonamide-based compounds Active 07-Apr-2022 A61K31/505
To view Mitos Therapeutics’s complete patent history, request access »

Mitos Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mitos Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
IBK Changgong Accelerator/Incubator
Chungnam National University Technology Holdings Venture Capital Minority
Daedeok Venture Partners Venture Capital Minority
Innocube Accelerator/Incubator Minority
Rowe Partners Accelerator/Incubator Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Mitos Therapeutics FAQs

  • When was Mitos Therapeutics founded?

    Mitos Therapeutics was founded in 2020.

  • Where is Mitos Therapeutics headquartered?

    Mitos Therapeutics is headquartered in Daejeon, South Korea.

  • What is the size of Mitos Therapeutics?

    Mitos Therapeutics has 7 total employees.

  • What industry is Mitos Therapeutics in?

    Mitos Therapeutics’s primary industry is Drug Discovery.

  • Is Mitos Therapeutics a private or public company?

    Mitos Therapeutics is a Private company.

  • What is Mitos Therapeutics’s current revenue?

    The current revenue for Mitos Therapeutics is .

  • How much funding has Mitos Therapeutics raised over time?

    Mitos Therapeutics has raised $396K.

  • Who are Mitos Therapeutics’s investors?

    IBK Changgong, Chungnam National University Technology Holdings, Daedeok Venture Partners, Innocube, and Rowe Partners are 5 of 7 investors who have invested in Mitos Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process